Published in Gene Therapy Weekly, June 9th, 1997
Two of these chimeras currently are being tested in chimpanzees, according to Gail Ferstandig Arnold and colleagues of Rutgers University, Piscataway, New Jersey.
Arnold reported the development of the candidate HIV vaccine in a poster presentation to the 9th Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS (NCVDG), held May 4-7, 1997, in Bethesda, Maryland.
"Seven of eight chimeric viruses used to immunize guinea pigs were able to elicit neutralizing antibody responses against the MN and ALA-1...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.